Video above: Legal challenges following the Dobbs Supreme Court decision

(The Hill) – The Food and Drug Administration (FDA) approved a new generic form of the abortion pill mifepristone this week, drawing upset from conservative voices.

On Tuesday, the FDA sent a letter to Evita Solutions, informing them that their abbreviated new drug application had met the necessary requirements and was approved.

"We have determined your Mifepristone Tablets, 200 mg to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mifeprex (mifepristone) tablets, 200 mg, of Danco Laboratories," the FDA's letter stated.

The FDA first approved mifepristone in 2000. Mifepristone is taken in combination with the drug misoprostol to perform medical abortions, which account for about

See Full Page